Profile

    Corporate information

    Official name
    Theregen Incorporated

    Registration country
    Investment activity status
    Active investor

    Company type

    Regenerative medicine company developing Anginera, an epicardial patch, for the treatment of heart disease.

    Funding rounds


    Profile Country Notes
    Sanderling Ventures United States

    Current and past shareholders

    Investor Contacts Round
    Sanderling Ventures logo Sanderling Ventures
    +1 (650) 401-2000
    N/A